Thymopentin in the Treatment of Severe Alopecia areata

Tosti, Antonella; Manuzzi, P.; Gasponi, A

doi:10.1159/000248537

Cited by 17 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…thymopentin) and topical cyclosporin could be a relatively new step in the management of alopecia areata, but further studies are required before a definitive judgement can be expressed. However, the results until now reported with these drugs are not particularly impressive [24][25][26].…”

Section: Treatment: Is It Worthwhile?mentioning

confidence: 97%

Alopecia areata: More on Pathogenesis and Therapy

Tosti

1989

Dermatology

Self Cite

View full text Add to dashboard Cite

Section: Treatment: Is It Worthwhile?mentioning

confidence: 97%

Alopecia areata: More on Pathogenesis and Therapy

Tosti

1989

Dermatology

Self Cite

View full text Add to dashboard Cite

“…It can induce T-cell differentiation and modulate the function of mature lymphocytes. 100 Thy¬ mopentin has been demonstrated to stimulate suppressor-cytotoxic T cells.102…”

Section: Inosiplexmentioning

confidence: 99%

Alopecia Areata

Fiedler¹

1992

Arch Dermatol

View full text Add to dashboard Cite

Although it is clear from the foregoing that some of the drugs and chemicals used to treat severe alopecia areata are efficacious to some degree, it is impossible to draw any meaningful comparisons among the data outlined in Tables 1 and 2. Virtually all of the studies were designed differently. Differences in chronicity and extent of disease as well as history of previous treatment resistance may significantly affect efficacy data even as two investigators compare the same drug. Drug-induced hair regrowth in alopecia areata may be very slow; a cosmetic response may take 1 to 2 years to achieve. Efficacy determinations made at shorter intervals may, therefore, not reflect true therapeutic potential. Efficacy end points vary significantly and need to be standardized. From a practical standpoint, scalp hair coverage that is deemed by the patient to be cosmetically acceptable seems to be a reasonable efficacy end point to report. Maintenance of cosmetic effect with continued treatment and/or following discontinuation of treatment also is useful to document. Table 3 outlines my approach to therapy of alopecia areata. Topical treatments often must be used for as long as 3 months before evidence of regrowth can be seen. In my experience with severe disease, if topical treatments cannot control a flare or induce regrowth, then the patient will often require either lengthy or frequent courses of systemic steroids. In my experience, prednisone doses as low as 20 mg/d may be associated with aseptic neurosis of the hip or severe gastrointestinal bleeding. Severe alopecia areata is a disease for which all therapies are, at best, palliative and, at worst, potentially harmful to patients who are usually otherwise very healthy. The psychosocial significance of this disease is enormous. The insights shared by a long-time sufferer of the disease mirror those expressed by the many patients with whom I have worked during the past 12 years. Three key elements to effectively treat the patient are (1) to help the patient understand the disease; (2) to encourage the patient to share his or her feelings with the physician, family, friends, and other sufferers of the disease; and (3) to help the patient to maintain a sense of hope for future scientific knowledge and treatment of the disease. With a thorough knowledge of the potential benefits and risks of each treatment or combination treatment, the physician with the patient's understanding and cooperation may then embark on what may be in severe cases a lengthy and sometimes unproductive therapeutic process.

show abstract

Alopecia areata. A review of therapy, efficacy, safety, and mechanism

Fiedler¹

1992

Archives of Dermatology

View full text Add to dashboard Cite

Thymopentin in the Treatment of Severe Alopecia areata

Cited by 17 publications

References 8 publications

Alopecia areata: More on Pathogenesis and Therapy

Alopecia areata: More on Pathogenesis and Therapy

Alopecia Areata

Alopecia areata. A review of therapy, efficacy, safety, and mechanism

Contact Info

Product

Resources

About